These results suggest that compared with 68Ga-PSMA-617 PET/CT, 18F-PSMA-1007 PET/CT shows equally good potential for PCa risk stratification and that TL-PSMAp has the best potential for identifying high-risk patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.